Germline gain-of-function (GoF) mutations in PTPN11, encoding SHP2, account for 50% of Noonan syndrome (NS) (Tartaglia et al. 2001, 2002), the most common and clinically variable among RASopathies (Tartaglia et al. 2011). The gene discussed is PTPN11; the disease is RASopathy.